Bavarian Nordic's biggest shareholder is trying to block a 19 billion krone ($3 billion) offer from Nordic Capital and Permira to take the vaccine maker private.
Why it matters: The opposition is casting doubt on the deal's prospects, which has been in the works for about a year.
